Source: International Congress 2019 – Chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Suda (Chiba, Japan), N. Tanabe (Chiba, Japan), K. Yamamoto (Chiba, Japan), A. Sasaki (Chiba, Japan), A. Sekine (Chiba, Japan), R. Nishimura (Chiba, Japan), T. Jujo (Chiba, Japan), A. Shigeta (Chiba, Japan), T. Sugiura (Chiba, Japan), S. Sakao (Chiba, Japan), K. Tatsumi (Chiba, Japan). Long-term follow-up data about chronic thromboembolic disease. 5165

Member's Comments

No comment yet.

Related content which might interest you: Prediction of exacerbation in one-year follow-up of patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020 Predictors of poor outcome in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Long-term outcomes of percutaneous coronary intervention in patients with chronic obstructive pulmonary disease: a 13-year nationwide cohort study Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function Year: 2017 Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease Source: Annual Congress 2004 - Treatment of pulmonary hypertension Year: 2004 The incidence of chronic thromboembolic pulmonary hypertension (CTEPH): a 25-year population-based study Source: Eur Respir J 2003; 22: Suppl. 45, 462s Year: 2003 Improved survival in medically-treated chronic thromboembolic pulmonary hypertension Source: Annual Congress 2011 - Treatment of human pulmonary hypertension Year: 2011 Long-term risks of cardiovascular events in patients with chronic kidney disease who survived sepsis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Three-year follow-up study of inflammatory markers in chronic obstructive pulmonary disease Source: Annual Congress 2011 - Challenges in chronic disease management: helping individuals with chronic lung disease remain stable Year: 2011 Outcome of pulmonary endarterectomy in symptomatic chronic thromboembolic disease Source: Eur Respir J 2014; 44: 1635-1645 Year: 2014 The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 52 (3) 1800589; 10.1183/13993003.00589-2018 Year: 2018 Predictors of survival of patients with chronic obstructive pulmonary disease in long-term oxygen therapy Source: Eur Respir J 2006; 28: Suppl. 50, 519s Year: 2006 Long-term follow-up of patients with pulmonary sarcoidosis Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Survival in patients with chronic thromboembolic pulmonary hypertension in the modern management era Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020 Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007 The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study Source: Eur Respir J 2006; 28: 138-143 Year: 2006 Adherence to treatment strategies correlates with the annual rate of hospitalizations and 1-year mortality in patients with chronic obstructive pulmonary disease Source: Annual Congress 2010 - Exacerbations and COPD and rehabilitation Year: 2010 Clinical presentation and outcomes of venous thrombo-embolic diseases in chronic obstructive pulmonary diseases. Findings from the RIETE Registry Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Longterm survival of inoperable chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2008 - Acute and chronic pulmonary thromboembolic disease Year: 2008 Acute effects, 1-year, and 2-year follow up of iloprost-aerosol therapy in severe primary pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001 Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011